Dent Neurologic



Your initial visit to The DENT Cannabis Clinic is to establish a provider-patient relationship and evaluate your eligibility for the program.

During that visit please expect the following:

  • Your clinical history, diagnostic studies and lab results will be reviewed.
  • A neurological examination will be performed.
  • Recommendations will be shared that may/may not include medical marijuana or a change in your current therapy.

A collaborative relationship will be established between your treating physician and our physician(s) within the DENT Neurologic Institute.

A follow up appointment will be scheduled at which point a discussion about the potential use of medical marijuana for the treatment of your medical condition will be discussed.


Laszlo Mechtler, MD, FAAN, FEAN, FASN, FAHS

Medical Director of Dent Neurologic Institute

Fran M. Gengo, PharmD, FCP

Director of Neuropharmacology and the Research Director for the Acute Stroke Treatment Program at DENT

Note: All physicians involved in the DENT Cannabis Clinic are registered by the New York State Medical Marijuana Program.

Please call 716.250.2000 to schedule a consultation to see if Medical Cannabis is an option for you.

For more information on New York State Law and Regulations on Medical Cannabis please visit New York State’s website.

Medical Cannabis in the Treatment of Parkinson's Disease

Medical cannabis (MC) has recently garnered interest as a potential treatment for neurologic diseases, including Parkinson's disease (PD). A retrospective chart review was conducted to explore the impact of MC on the symptomatic treatment of patients with PD.

Link to Pubmed

Medical Cannabis in the Treatment of Parkinson's Disease
Click Here

Cannabuff Editorials

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Scroll to Top